Department of Science and Technology Undersecretary Rowena Cristina Guevara, who chairs the Task Group on Vaccine Evaluation and Selection (TG-VES) said the platform used by Sinovac Biotech in producing its coronavirus disease (COVID-19) vaccine is inactivated virus, which is the "most tried and te